Eagle Health Investments LP - Q1 2023 holdings

$514 Million is the total value of Eagle Health Investments LP's 27 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 42.9% .

 Value Shares↓ Weighting
NTRA SellNATERA INC$43,577,315
+33.1%
784,894
-3.7%
8.48%
+12.3%
ALNY SellALNYLAM PHARMACEUTICALS INC$27,394,962
-26.0%
136,756
-12.2%
5.33%
-37.5%
OM SellOUTSET MED INC$22,087,084
-29.9%
1,200,385
-1.7%
4.30%
-40.9%
TNDM SellTANDEM DIABETES CARE INC$17,280,570
-34.9%
425,525
-27.9%
3.36%
-45.1%
ARVN ExitARVINAS INC$0-23,000
-100.0%
-0.18%
TXG Exit10X GENOMICS INC$0-49,200
-100.0%
-0.41%
CTLT ExitCATALENT INC$0-329,100
-100.0%
-3.42%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IQVIA HLDGS INC12Q3 20239.6%
UNITED THERAPEUTICS CORP DEL12Q3 20238.7%
ALNYLAM PHARMACEUTICALS INC12Q3 20238.5%
NATERA INC12Q3 20238.5%
ARGENX SE12Q3 20237.0%
DEXCOM INC12Q3 20235.7%
OUTSET MED INC12Q3 20237.3%
AGIOS PHARMACEUTICALS INC12Q3 20237.2%
ADAPTIVE BIOTECHNOLOGIES COR12Q3 20235.1%
GUARDANT HEALTH INC12Q3 20233.8%

View Eagle Health Investments LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-10-27
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-02-10
13F-HR2021-10-20

View Eagle Health Investments LP's complete filings history.

Compare quarters

Export Eagle Health Investments LP's holdings